Skip to main content
logo
Firebrick Pharma Limited (ASX:FRE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0300
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST

Firebrick Pharma Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
1.320.980.822.357.14
Cash & Short-Term Investments
1.320.980.822.357.14
Cash Growth
34.38%19.23%-64.97%-67.04%514.47%
Accounts Receivable
0.010.010--
Other Receivables
0.040.250.950.141.08
Receivables
0.050.260.950.141.08
Inventory
0.360.190.24--
Other Current Assets
0.120.050.080.10.1
Total Current Assets
1.861.482.092.598.33
Property, Plant & Equipment
0.110.090.030.030.04
Other Long-Term Assets
0.190.250.290.360.36
Total Assets
2.171.832.412.988.73

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.20.110.070.20.04
Accrued Expenses
0.230.120.10.140.34
Other Current Liabilities
0.050.040.120.170.08
Total Current Liabilities
0.480.270.290.510.45
Total Liabilities
0.480.270.290.510.45

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
22.6719.7717.8817.0716
Retained Earnings
-21.55-18.79-16.51-15.58-8.81
Comprehensive Income & Other
0.560.570.740.991.08
Shareholders' Equity
1.681.562.122.488.28
Total Liabilities & Equity
2.171.832.412.988.73

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
1.320.980.822.357.14
Net Cash Growth
34.38%19.23%-64.97%-67.04%514.47%
Net Cash Per Share
0.010.000.000.010.06
Filing Date Shares Outstanding
285.2227.32195.31176.25169.2
Total Common Shares Outstanding
285.2224.58195.31176.25168.84
Working Capital
1.381.211.82.087.88
Book Value Per Share
0.010.010.010.010.05
Tangible Book Value
1.681.562.122.488.28
Tangible Book Value Per Share
0.010.010.010.010.05